Jennifer Odoi

Graduate Trainee, University of Texas Medical Branch (UTMB) at Galveston

1 active project

Disparity in Uterine Cancer

When comparing non-Hispanic Black women with uterine cancer, what are differences between the groups with good outcomes (early stage at diagnosis, survival at 3 and 5 years) vs. poor outcomes (stage 3+ at diagnosis, mortality at 3 and 5 years)?…

Scientific Questions Being Studied

When comparing non-Hispanic Black women with uterine cancer, what are differences between the groups with good outcomes (early stage at diagnosis, survival at 3 and 5 years) vs. poor outcomes (stage 3+ at diagnosis, mortality at 3 and 5 years)?
What are the modifiable risk factors in the group with poor outcomes?
Could knowledge of these differences be utilized in an educational program to help decrease the disparities in outcomes?

Project Purpose(s)

  • Disease Focused Research (uterine cancer)
  • Population Health

Scientific Approaches

We plan to conduct a chart review with the following inclusion and exclusion criteria.

Inclusion criteria include the following:
1. Age greater than or equal to 18 years
2. Black race
3. Diagnosis of endometrial and/or uterine cancer

Exclusion criteria include the following:
1. Concurrent breast or color or other primary cancer
2. Immunosuppressive disease

Records will be collected based on the following filters:
1. Age, sex
2. Diagnosis

The following data will be collected from each record.
1. Age, sex
2. Race, ethnicity
3. Tumor type
4. Tumor stage
5. Treatment
6. Age at menopause
7. Age at menarche
8. G’/P’s
9. Hormonal contraception
10. Fibroids
11. BMI, dx of obesity
12. Metabolic syndrome
13. Tobacco use
14. Diabetes, HTN
15. Hx polyps
16. Hx post-menopausal bleeding
17. Hx menorrhagia
18. Hx metrorrhagia
19. Family hx – CA, hysterectomy
20. Socioeconomic – insurance/access to medical care
21. Hx of assault or domestic violence

Anticipated Findings

We anticipate that there will be both modifiable and non-modifiable risk factors associated with a poor prognosis. For example, we expect that women who have had irregular or heavy menstrual cycles, barriers to accessing medical care, history of assault or domestic violence, and comorbidities, such as metabolic syndrome and hypertension, will have poorer outcomes (higher stage at diagnosis, lower survival rate at 3 or 5 years).

We expect that programs geared towards modifiable risk factors and that educate women about expectations during menopause and perimenopause may reduce delay to diagnosis and increase early stage diagnosis of cancer, and potentially lead to better outcomes.

Most studies compare between racial groups. There is a paucity of literature on comparisons within women of the same race with good vs. poor prognosis.

Demographic Categories of Interest

  • Race / Ethnicity

Data Set Used

Registered Tier

Research Team

Owner:

  • Jennifer Odoi - Graduate Trainee, University of Texas Medical Branch (UTMB) at Galveston
1 - 1 of 1
<
>
Request a Review of this Research Project

You can request that the All of Us Resource Access Board (RAB) review a research purpose description if you have concerns that this research project may stigmatize All of Us participants or violate the Data User Code of Conduct in some other way. To request a review, you must fill in a form, which you can access by selecting ‘request a review’ below.